Table 1:
Peri-implantation parameters as predictors of medium-term survival
| n | Median (IQR) or frequency (%) | HR | P-value | |
|---|---|---|---|---|
| Age (years) | 79 | 51.0 (43.0–60.0) | 1.06 | <0.001 |
| Female | 79 | 18 (22.8) | 1.05 | 0.91 |
| Out-of-centre implantation | 79 | 27 (34.2) | 1.12 | 0.78 |
| Awake at implantation | 79 | 11 (13.9) | 1.00 | 1.00 |
| Aetiology | ||||
| Acute coronary syndrome | 79 | 43 (54.4) | 0.88 | 0.73 |
| Cardiomyopathy/myocarditis | 79 | 24 (30.4) | 1.16 | 0.72 |
| Others | 79 | 12 (15.2) | 1.02 | 0.98 |
| INTERMACS | 79 | 1.0 (1.0–2.0) | 0.89 | 0.79 |
| CPR | 79 | 49 (62.0) | 1.04 | 0.92 |
| Implantation during CPR (ECPR) | 79 | 15 (19.0) | 0.61 | 0.36 |
| pH pre-implantation | 78 | 7.30 (7.20–7.38) | 1.55 | 0.69 |
| pH 6 h post-implantation | 78 | 7.38 (7.30–7.44) | 6.38 | 0.35 |
| Lactate pre-implantation (mmol/l) | 78 | 7.1 (3.5–12.4) | 1.00 | 0.91 |
| Lactate 6 h post-implantation (mmol/l) | 78 | 4.8 (2.4–8.7) | 0.99 | 0.83 |
| Lactate clearance (h) | 79 | 21.0 (9.0–39.0) | 1.00 | 0.96 |
| Maximum bilirubin within initial 24 h (mg/dl) | 76 | 1.8 (1.1–2.8) | 1.00 | 1.00 |
| Maximum glutamic oxaloacetic transaminase (GOT) within initial 24 h (U/l) | 76 | 455.0 (235.0–1128.5) | 1.00 | 0.61 |
| Maximum glutamic-pyruvic transaminase (GPT) within initial 24 h (U/l) | 77 | 188.0 (87.0–540.5) | 1.00 | 0.78 |
CPR: cardiopulmonary resuscitation; HR: hazard ratio; IQR: interquartile range.